Published in Nat New Biol on July 21, 1971
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77
In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med (1972) 2.13
The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection. J Exp Med (1973) 1.68
Characterization of human lymphoid cell-mediated antibody-dependent cytotoxicity (LDAC). Clin Exp Immunol (1974) 1.50
Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B-cell Ia-like molecule. J Exp Med (1976) 1.41
Antibody-dependent cellular cytotoxicity by allosensitized human T cells. J Exp Med (1978) 1.35
Selective deficiency of cytotoxic B lymphocytes in man. Clin Exp Immunol (1972) 1.30
Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by IgG antibody but not by target cell-bound C3. J Exp Med (1975) 1.28
Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants. J Exp Med (1973) 1.22
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. Br J Cancer (1977) 1.18
Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts. Clin Exp Immunol (1973) 1.08
Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes. J Exp Med (1977) 1.08
Development of cellular immunity in the human fetus: dichotomy of proliferative and cytotoxic responses of lymphoid cells to phytohemagglutinin. Proc Natl Acad Sci U S A (1972) 1.04
Cytotoxic immune cells with specificity for defined soluble antigens. IV. Antibody as mediator of specific cytotoxicity. J Exp Med (1974) 1.04
Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells. J Exp Med (1973) 0.98
IgM-induced tumor cell cytotoxicity mediated by normal thymocytes. J Exp Med (1975) 0.89
Antibody-mediated suppression of lymphoma: participation of platelets, lymphocytes, and nonphagocytic macrophages. Proc Natl Acad Sci U S A (1974) 0.88
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions. Clin Exp Immunol (1979) 0.87
Quantitation of potential T-lymphocyte function in rats. Infect Immun (1975) 0.79
Role of lymphocytes in non-immune experimental inflammation. Agents Actions (1981) 0.75
The time relations of the photo-electric changes in the eyeball of the frog. J Physiol (1903) 31.79
The delay of the electrical response of nerve to a second stimulus. J Physiol (1910) 9.35
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22
Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev (1972) 4.79
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
A common molecular basis for three inherited kidney stone diseases. Nature (1996) 4.26
Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet (1986) 3.64
A clinicopathological study of autism. Brain (1998) 3.49
A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology (1969) 3.12
Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain (2000) 2.96
Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature (1968) 2.96
Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77
GATA3 haplo-insufficiency causes human HDR syndrome. Nature (2000) 2.73
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 2.71
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57
Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol (1988) 2.26
Germinal centers without T cells. J Exp Med (2000) 2.25
Temperature and Excitability. J Physiol (1896) 2.21
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol (1981) 2.08
The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology (1970) 1.96
Outcome of anorexia nervosa. Lancet (1979) 1.94
Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol (2001) 1.92
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91
Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol (1986) 1.89
The time-relations of the photo-electric changes produced in the eyeball of the frog by means of coloured light. J Physiol (1904) 1.88
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med (2000) 1.87
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol (1991) 1.82
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
CD23: a multi-functional receptor/lymphokine? Immunol Today (1989) 1.76
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol (1982) 1.71
Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62
Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet (1995) 1.62
A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med (1995) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
A prospective study of hepatic tuberculosis in 41 black patients. Q J Med (1987) 1.49
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48
Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol (1988) 1.48
Germline and mosaic mutations of FLN1 in men with periventricular heterotopia. Neurology (2004) 1.47
Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46
The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro. Clin Exp Immunol (1968) 1.46
Note on the so-called Tendon Reflex. J Physiol (1896) 1.46
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
Dendritic cells associated with plasmablast survival. Eur J Immunol (1999) 1.44
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence. Brain (2003) 1.40
Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis (1972) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol (1999) 1.39
Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol (2001) 1.38
The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol (1981) 1.37
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol (1981) 1.36
Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG. Immunology (1974) 1.36
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35
The IgG subclass responses of human lymphocytes to B-cell activators. Immunology (1983) 1.35
Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur J Immunol (1986) 1.31
Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur J Immunol (1987) 1.30
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol (1998) 1.30
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol (1992) 1.29
Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes. Immunology (1973) 1.29
Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology (1984) 1.28
The electrical response of nerve to two stimuli. J Physiol (1899) 1.27
Evidence for correlation between the antigenic specificity and charge of human IgG. A study of antibody-inducing lymphocyte mediated cell damage. Immunology (1972) 1.25
Is rapid proliferation in B centroblasts linked to somatic mutation in memory B cell clones? Immunol Lett (1988) 1.24
The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans (1992) 1.23
Quantitative analysis of molecules which distinguish functional compartments within germinal centers. Eur J Immunol (1993) 1.20
Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol (2009) 1.20
Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis (1976) 1.20
Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol (2001) 1.19
Anorexia nervosa. Psychoneurotic characteristics of parents: relationship to prognosis. A quantitative study. J Psychosom Res (1974) 1.18
UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab (2003) 1.18
Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens. Transplantation (1973) 1.17
Results of the MRC myelomatosis trials for patients entered since 1980. Hematol Oncol (1988) 1.15
The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology (1972) 1.15
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer (1985) 1.15
Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol (1986) 1.14
Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology (1984) 1.14
On the Electrical Organ of the Skate. J Physiol (1888) 1.13
Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol (1995) 1.12
Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction. Eur J Immunol (1993) 1.11